Literature DB >> 9359725

Human immune response to nontypeable Haemophilus influenzae in chronic bronchitis.

K Yi1, S Sethi, T F Murphy.   

Abstract

Nontypeable Haemophilus influenzae (NTHI) causes recurrent respiratory tract infections in patients with chronic bronchitis. To elucidate the human immune response to NTHI, sera from 2 patients with exacerbations of chronic bronchitis due to NTHI were characterized. Both patients developed new bactericidal antibodies following infection. Immunoblot assays with homologous strains revealed antibodies to many antigens, with minimal difference between pre- and postexacerbation sera. By contrast, whole cell radioimmunoprecipitation, which detects antibodies exclusively to epitopes exposed on the bacterial surface, revealed that both patients made new antibodies to a limited number of antigens following infection, including P2, the major outer membrane protein of NTHI. Adsorption experiments showed that strain-specific, surface-exposed epitopes on the P2 molecule are targets for bactericidal antibodies. These results indicate that new bactericidal antibodies following infection by NTHI recognize antigenically heterogeneous surface-exposed epitopes on P2 and other surface proteins of NTHI.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9359725     DOI: 10.1086/514119

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  28 in total

1.  Antibodies to loop 6 of the P2 porin protein of nontypeable Haemophilus influenzae are bactericidal against multiple strains.

Authors:  J M Neary; K Yi; R J Karalus; T F Murphy
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

2.  Uptake of Sialic Acid by Nontypeable Haemophilus influenzae Increases Complement Resistance through Decreasing IgM-Dependent Complement Activation.

Authors:  Marjolein M P Oerlemans; Sam J Moons; Jurriaan J A Heming; Thomas J Boltje; Marien I de Jonge; Jeroen D Langereis
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

3.  Binding of human factor H to outer membrane protein P5 of non-typeable Haemophilus influenzae contributes to complement resistance.

Authors:  Jeroen D Langereis; Marien I de Jonge; Jeffrey N Weiser
Journal:  Mol Microbiol       Date:  2014-08-18       Impact factor: 3.501

4.  Mucosal immunization of mice with recombinant OMP P2 induces antibodies that bind to surface epitopes of multiple strains of nontypeable Haemophilus influenzae.

Authors:  K L Ostberg; M W Russell; T F Murphy
Journal:  Mucosal Immunol       Date:  2008-10-29       Impact factor: 7.313

5.  Lipooligosaccharides containing phosphorylcholine delay pulmonary clearance of nontypeable Haemophilus influenzae.

Authors:  Bing Pang; Dana Winn; Ryan Johnson; Wenzhou Hong; Shayla West-Barnette; Nancy Kock; W Edward Swords
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

6.  Proteomic expression profiling of Haemophilus influenzae grown in pooled human sputum from adults with chronic obstructive pulmonary disease reveal antioxidant and stress responses.

Authors:  Jun Qu; Alan J Lesse; Aimee L Brauer; Jin Cao; Steven R Gill; Timothy F Murphy
Journal:  BMC Microbiol       Date:  2010-06-01       Impact factor: 3.605

Review 7.  Chronic obstructive pulmonary disease: role of bacteria and updated guide to antibacterial selection in the older patient.

Authors:  G Iyer Parameswaran; Timothy F Murphy
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

8.  Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis.

Authors:  A J White; S Gompertz; D L Bayley; S L Hill; C O'Brien; I Unsal; R A Stockley
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

Review 9.  Pathogen-directed therapy in acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Fernando J Martinez
Journal:  Proc Am Thorac Soc       Date:  2007-12

Review 10.  Role of macrolide therapy in chronic obstructive pulmonary disease.

Authors:  Fernando J Martinez; Jeffrey L Curtis; Richard Albert
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.